Skip to main content

Table 3 Number (%) patients who improved, maintained or worsened SABA-free days from first to last month of monitoring (n = 51)

From: Retrospective assessment of a collaborative digital asthma program for Medicaid-enrolled children in southwest Detroit: reductions in short-acting beta-agonist (SABA) medication use

Change over time

N (%)

Improved

40 (78.4)

Maintained

3 ( 5.9)

Worsened

8 (15.7)

Back to article page

Asthma Research and Practice

ISSN: 2054-7064

Contact us